» Articles » PMID: 35626705

Integrated Analysis of Cancer Tissue and Vitreous Humor from Retinoblastoma Eyes Reveals Unique Tumor-Specific Metabolic and Cellular Pathways in Advanced and Non-Advanced Tumors

Abstract

Retinoblastoma (Rb) is a pediatric intraocular malignancy that is proposed to originate from maturing cone cell precursors in the developing retina. The molecular mechanisms underlying the biological and clinical behaviors are important to understand in order to improve the management of advanced-stage tumors. While the genetic causes of Rb are known, an integrated understanding of the gene expression and metabolic processes in tumors of human eyes is deficient. By integrating transcriptomic profiling from tumor tissues and metabolomics from tumorous eye vitreous humor samples (with healthy, age-matched pediatric retinae and vitreous samples as controls), we uncover unique functional associations between genes and metabolites. We found distinct gene expression patterns between clinically advanced and non-advanced Rb. Global metabolomic analysis of the vitreous humor of the same Rb eyes revealed distinctly altered metabolites, indicating how tumor metabolism has diverged from healthy pediatric retina. Several key enzymes that are related to cellular energy production, such as hexokinase 1, were found to be reduced in a manner corresponding to altered metabolites; notably, a reduction in pyruvate levels. Similarly, E2F2 was the most significantly elevated E2F family member in our cohort that is part of the cell cycle regulatory circuit. Ectopic expression of the wild-type gene in the Rb-null Y79 and WERI-Rb1 cells rescued hexokinase 1 expression, while E2F2 levels were repressed. In an additional set of Rb tumor samples and pediatric healthy controls, we further validated differences in the expression of HK1 and E2F2. Through an integrated omics analysis of the transcriptomics and metabolomics of Rb, we uncovered a significantly altered tumor-specific metabolic circuit that reduces its dependence on glycolytic pathways and is governed by Rb1 and HK1.

Citing Articles

Circ_103809 Aggravates the Malignant Phenotype of Pancreatic Cancer Through Modulating miR-197-3p/TSPAN3 Axis.

Wu X, Zhou S, Wang L, Ma J, Zhou Y, Ruan Y Mol Biotechnol. 2023; 66(9):2455-2466.

PMID: 37740818 DOI: 10.1007/s12033-023-00874-0.


Genetics in ophthalmology: molecular blueprints of retinoblastoma.

Markovic L, Bukovac A, Varosanec A, Slaus N, Pecina-Slaus N Hum Genomics. 2023; 17(1):82.

PMID: 37658463 PMC: 10474694. DOI: 10.1186/s40246-023-00529-w.


MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma.

Romani A, Zauli E, Zauli G, AlMesfer S, Al-Swailem S, Voltan R Front Oncol. 2022; 12:1000677.

PMID: 36338723 PMC: 9632280. DOI: 10.3389/fonc.2022.1000677.


Lack of Retinoblastoma Protein Shifts Tumor Metabolism from Glycolysis to OXPHOS and Allows the Use of Alternate Fuels.

Babu V, Dudeja G, Sa D, Bisht A, Shetty R, Heymans S Cells. 2022; 11(20).

PMID: 36291051 PMC: 9600484. DOI: 10.3390/cells11203182.

References
1.
Dimaras H, Corson T, Cobrinik D, White A, Zhao J, Munier F . Retinoblastoma. Nat Rev Dis Primers. 2016; 1:15021. PMC: 5744255. DOI: 10.1038/nrdp.2015.21. View

2.
Kin N, Sanders V . CD86 regulates IgG1 production via a CD19-dependent mechanism. J Immunol. 2007; 179(3):1516-23. DOI: 10.4049/jimmunol.179.3.1516. View

3.
Yang B, Dai J, Pan Y, Ma Y, Chu S . Examining the biomarkers and molecular mechanisms of medulloblastoma based on bioinformatics analysis. Oncol Lett. 2019; 18(1):433-441. PMC: 6540325. DOI: 10.3892/ol.2019.10314. View

4.
Etemad S, Petit M, Weiss A, Schrattenholz A, Baraldo G, Jansen-Durr P . Oxaloacetate decarboxylase FAHD1 - a new regulator of mitochondrial function and senescence. Mech Ageing Dev. 2018; 177:22-29. DOI: 10.1016/j.mad.2018.07.007. View

5.
Liu J, Ottaviani D, Sefta M, Desbrousses C, Chapeaublanc E, Aschero R . A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression. Nat Commun. 2021; 12(1):5578. PMC: 8458383. DOI: 10.1038/s41467-021-25792-0. View